Fluidigm Receives Life Science Industry Award for the Maxpar Direct Immune Profiling SystemGlobeNewsWire • 12/09/19
Fluidigm Corporation Announces Pricing of Private Offering of $50 Million of 5.25% Convertible Senior NotesGlobeNewsWire • 11/20/19
Fluidigm Corporation Announces Proposed Private Offering of $45 Million of Convertible Senior NotesGlobeNewsWire • 11/20/19
Fluidigm Corporation (FLDM) CEO Chris Linthwaite on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/06/19
Fluidigm (FLDM) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 10/29/19
Fluidigm Showcases RNA Sequencing Innovations Using Microfluidics Technology at the 2019 American Society of Human Genetics (ASHG) MeetingGlobeNewsWire • 10/15/19
Fluidigm Becomes the First Company to Enable 50-Plex Cytometry Panels with the Release of Seven New Metal Antibody LabelsGlobeNewsWire • 09/24/19
CyTOF Inventors Receive Prestigious Science and Technology Award from the Human Proteome Organization (HUPO)GlobeNewsWire • 09/18/19
Fluidigm Revolutionizes Next-Generation Sequencing RNA Library Preparation with Microfluidic AutomationGlobeNewsWire • 09/09/19
Fluidigm Launches Imaging Mass Cytometry Immuno-Oncology Panel Kits and Advanced CyTOF Software at the 2019 World Molecular Imaging Congress (WMIC)GlobeNewsWire • 09/04/19
Fluidigm Corporation (FLDM) CEO Chris Linthwaite on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/02/19
Fluidigm Corp (FLDM) CEO Stephen Linthwaite on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/05/19